Glenmark Pharmaceuticals receives ANDA approval for Tacrolimus Capsules

▴ Glenmark Pharmaceuticals receives ANDA approval for Tacrolimus Capsules
Glenmark has been granted final approval by the U.S. FDA for Tacrolimus Capsules USP, the generic version of Prograf Capsules, of Astellas Pharm US, Inc.

Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Tacrolimus Capsules USP, 0.5 mg, 1 mg and 5 mg, the generic version of Prograf Capsules, 0.5 mg, 1 mg and 5 mg, of Astellas Pharm US, Inc.

According to IQVIA sales data for the 12 month period ending September 2020, the Prograf Capsules, 0.5 mg, 1 mg and 5 mg market achieved annual sales of approximately $286.8 million*.

Glenmark’s current portfolio consists of 166 products authorized for distribution in the U.S. marketplace and 45 ANDA’s pending approval with the U.S. FDA. In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.

Glenmark Pharmaceuticals Ltd. (GPL) is a global research-led pharmaceutical company with presence across Generics, Specialty and OTC business with operations in over 50 countries. Glenmark’s key therapy focus areas globally are respiratory, dermatology and oncology. It is ranked among the top 80 Pharma & Biotech companies of the world in terms of revenue.

Tags : #LatestPharmaNewsNov11 #LatestGlenmarkNewsNov11 #TreatmentofEczema #TreatmentofPsoriosis

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Walking 30 Minutes a Day: A Simple Proven Solution to Lower Back Pain RecurrenceJune 22, 2024
Tragic Illicit Liquor Incident in Kallakurichi: Rising Deaths Prompt Swift Government ActionJune 22, 2024
Gleneagles Hospital Kengeri Launches South India's First 5G-Enabled Ambulance Service in Partnership with MedulanceJune 21, 2024
Asaya's Mission to Redefine Skincare for Melanin-Rich Individuals Gains MomentumJune 21, 2024
Alyve Health Gains $5.5 Million Funding to Expand and Innovate Health TechJune 21, 2024
Mobile-health Network Solutions [MaNaDr] to Offer GLP-1 Injectables for Medical Weight Loss from USD10/DayJune 20, 2024
Understanding Hemophilia: The Hidden Disorder Affecting Many in IndiaJune 20, 2024
Reducing the Risk of Childbirth Injuries: The Role of Lateral EpisiotomyJune 20, 2024
New Study Reveals How Menopause Affects Kidney Function and Dental HealthJune 20, 2024
Alka Yagnik Opens Up About Rare Hearing Loss and Importance of Hearing HealthJune 20, 2024
Severe Heatwave Grips Delhi: Over 19 Deaths Reported Amid Sweltering TemperaturesJune 20, 2024
Healthy Living at the Grassroots: PM Modi's Holistic Approach with Yoga and MilletsJune 20, 2024
A First-of-its-Kind Landmark Minimally Invasive Heart Surgery Saves Dog in IndiaJune 20, 2024
Japan Battles Surge in Deadly Streptococcal Toxic Shock Syndrome CasesJune 20, 2024
HRS Navigation announces aggressive hiring plans for its R&D and Clinical Support teamsJune 19, 2024
Vikram Solar Wins 393.9 MWp Module Supply Order for NLC India’s Khavda Solar ProjectJune 18, 2024
AIMS Organizes Blood Donation Camp on World Blood Donor DayJune 17, 2024
Preparing for the Future: FDA's New COVID-19 Vaccine Recommendation Focuses on KP.2June 17, 2024
From Pap Tests to HPV Screening: A New Era in Cervical Cancer PreventionJune 17, 2024
HR Conclave Focusing on Future-Forward Engineering heldJune 15, 2024